Position in AMGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$3,717,523
-$67,679 QoQ
Shares Held
10,266
-4.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
#346
of 1,375 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VALLEY NATIONAL ADVISERS INC holds $26,573,081 across 16 Drug Manufacturers - General names. AMGN ranks #4 (14.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,036 | $6,040,329 | |
| 2 | MRK |
Merck & Co., Inc.
|
44,957 | $5,776,974 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
30,848 | $3,897,336 | |
| 4 | AMGN |
Amgen Inc
This page
|
10,266 | $3,717,523 | |
| 5 | AZN |
Astrazeneca PLC
|
13,217 | $2,506,207 | |
| 6 | ABBV |
AbbVie Inc.
|
5,759 | $1,449,194 | |
| 7 | NVS |
Novartis AG
|
7,794 | $1,221,475 | |
| 8 | JNJ |
Johnson & Johnson
|
3,962 | $1,006,229 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,717,523 | 10,266 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,785,202 | 10,758 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $3,528,729 | 10,781 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $3,063,562 | 10,856 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $3,036,128 | 10,874 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $3,494,656 | 11,217 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $3,169,382 | 12,160 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $4,360,790 | 13,534 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $7,384,442 | 23,634 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $6,984,604 | 24,566 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $7,241,974 | 25,144 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $7,076,988 | 26,332 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,920,163 | 26,665 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $6,451,581 | 26,687 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $7,065,016 | 26,900 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $6,226,900 | 27,626 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $6,540,877 | 26,884 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $6,471,586 | 26,762 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $5,938,083 | 26,395 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $5,718,371 | 26,891 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $6,638,043 | 27,233 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $6,818,638 | 27,405 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $6,431,782 | 27,974 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $7,372,164 | 29,006 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $7,102,923 | 30,115 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $6,378,493 | 31,463 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||